Rachel Chapla

Dr. Rachel Chapla


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
RCRachel Chapla
Rachel Chapla
KHKatherine Trang Huynh
Katherine Trang Huynh
CICarolyn Schutt Ibsen
Carolyn Schutt Ibsen
Targeted delivery of therapeutics to specific tissues is critically important for reducing systemic toxicity and optimizing therapeutic efficacy, especially in the case of cytotoxic drugs. Many strategies currently exist for targeting systemically administered drugs, and ultrasound-controlled targeting is a rapidly advancing strategy for externally-stimulated drug delivery. In this non-invasive method, ultrasound waves penetrate through tissue and stimulate gas-filled microbubbles, resulting in bubble rupture and biophysical effects that power delivery of attached cargo to surrounding cells. Drug delivery capabilities from ultrasound-sensitive microbubbles are greatly expanded when nanocarrier particles are attached to the bubble surface, and cargo loading is determined by the physicochemical properties of the nanoparticles. This review serves to highlight and discuss current microbubble–nanoparticle complex component materials and designs for ultrasound-mediated drug delivery. Nanocarriers that have been complexed with microbubbles for drug delivery include lipid-based, polymeric, lipid–polymer hybrid, protein, and inorganic nanoparticles. Several schemes exist for linking nanoparticles to microbubbles for efficient nanoparticle delivery, including biotin–avidin bridging, electrostatic bonding, and covalent linkages. When compared to unstimulated delivery, ultrasound-mediated cargo delivery enables enhanced cell uptake and accumulation of cargo in target organs and can result in improved therapeutic outcomes. These ultrasound-responsive delivery complexes can also be designed to facilitate other methods of targeting, including bioactive targeting ligands and responsivity to light or magnetic fields, and multi-level targeting can enhance therapeutic efficacy. Microbubble–nanoparticle complexes present a versatile platform for controlled drug delivery via ultrasound, allowing for enhanced tissue penetration and minimally invasive therapy. Future perspectives for application of this platform are also discussed in this review.

21 December 2020 in Progress in Biomedical Engineering
Verified
Journal Article
Closed access
RCRachel Chapla
Rachel Chapla
JWJennifer L West
Jennifer L West
Biomaterials can be intentionally designed to support and even guide vascularization for applications ranging from engineered organs to treatment of ischemic diseases like myocardial infarction and stroke. In order to appropriately design bioactive biomaterials for vascularization, it is important to understand the cellular and molecular events involved in angiogenesis and vasculogenesis. Cell-matrix and signaling biomolecule interactions that initiate and promote formation of vasculature in vivo can often be mimicked in biomaterial platforms. Hydrogels are frequently used in these applications because they are soft and hydrated with mechanical properties similar to soft tissues and because many synthetic hydrogels are essentially bioinert, allowing one to engineer in specific cell-material interactions. A variety of both naturally-derived and synthetic hydrogel bases are used for supporting vascularization, and these gels are tailored to possess mechanical properties, biodegradation, cell adhesive interactions, biochemical signaling, and/or architectural properties that can promote assembly and tubulogenesis by vascular cells. This article serves to review current hydrogel materials and the innovative design modifications implemented to guide and support the vascularization process.

6 December 2021 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Closed access
RCRachel Chapla
Rachel Chapla
JHJoshua A. Hammer
Joshua A. Hammer
AWand Dr. Jennifer West
and Dr. Jennifer West

12 February 2024 in Cellular and Molecular Bioengineering
Verified
Journal Article
Closed access
PDF file
RCRachel Chapla
Rachel Chapla
RKRachel R. Katz
Rachel R. Katz
AWand Dr. Jennifer West
and Dr. Jennifer West